Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: A randomized, placebo controlled 12-week clinical trial

Medicine and Dentistry

• Adverse Event 30%
• Amaurosis 10%
• Bladder Capacity 10%
• Bladder Function 10%
• Bladder Outlet Obstruction 20%
• Clinical Trial 10%
• Controlled Clinical Trial 10%
• Detrusor 40%
• International Prostate Symptom Score 30%
• Lower Urinary Tract Symptom 50%
• Man 40%
• Patient 10%
• Placebo 50%
• Prostate Hypertrophy 50%
• Tadalafil 100%
• Therapeutic Procedure 40%
• Urine Flow Rate 40%
• Urodynamics 70%